CBL Patras

CBL Patras (Chemical and Biopharmaceutical Laboratories of Patras) is a premier peptide technology company and Contract Development and Manufacturing Organization (CDMO) headquartered in Greece. Established in 1990 by Professor Kleomenis Barlos, the company is globally recognized for its pioneering work in peptide synthesis, particularly the development of the Barlos resin (2-chlorotrityl chloride resin). CBL Patras offers a comprehensive suite of services including the production of protected amino acids, specialized resins, and GMP-compliant peptide manufacturing at various scales. The company supports the pharmaceutical industry through process development and the supply of both generic and custom therapeutic peptides. With advanced facilities for solid-phase, liquid-phase, and hybrid synthesis, CBL Patras is a critical partner in the global peptide drug supply chain.